Newsletter Archive
-
05.13.26 -- How Commercial Leaders Can Optimize Their Relationships With The Board
5/13/2026
05/13/26 Life Science Leader Newsletter
-
05.13.26 -- How MTP Is Transforming Pharma Production Lines
5/13/2026
05/13/26 Life Science Leader Newsletter
-
05.11.26 -- The East Is Ready: A New Axis Of Pharmaceutical Innovation
5/11/2026
05/11/26 Life Science Leader Newsletter
-
05.09.26 -- Life Science Leader - Best Of April
5/9/2026
05/09/26 Life Science Leader Newsletter
-
05.08.26 -- Implementing A New CEO Strategy With NervGen Leaders
5/8/2026
05/08/26 Life Science Leader Newsletter
-
05.07.26 -- Enabling Next-Generation Modalities Through Integrated Analytical Process Expertise
5/7/2026
05/07/26 Life Science Leader Newsletter
-
05.04.26 -- Why Europe's Scientific Edge Still Struggles To Attract Global Capital
5/4/2026
05/04/26 Life Science Leader Newsletter
-
05.01.26 -- Reprogramming T Cells And Reducing Manufacturing Costs With Michael McCullar
5/1/2026
05/01/26 Life Science Leader Newsletter
-
05.01.26 -- New Podcast Episodes: Reprogramming T Cells, Radiotherapeutics, Rewriting Disease Biology
5/1/2026
05/01/26 Life Science Leader Newsletter
-
04.29.26 -- The Impact Of FDA Risk On Biotech Rewards With CFO And Board Director Allan Shaw
4/29/2026
04/29/26 Life Science Leader Newsletter